Certara

With Certara IQ™, one QSP platform supports EFA, FIH, and RP2D—connecting mechanism, PK/PD, and disease biology to move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

Fewer late-stage surprises start with earlier insight. Certara IQ™ turns QSP into a scalable decision engine—helping teams identify infeasible programs earlier, reduce dose uncertainty, and make faster go/no-go decisions. Book a demo: ow.ly/QgUi50Y0e59 #QSP #MIDD

With Certara IQ™, one QSP platform supports EFA, FIH, and RP2D—connecting mechanism, PK/PD, and disease biology to move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

🚀Big news from Certara at #BIOInternational 2026! Launching 𝗕𝗶𝗼 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗖𝗮𝘁𝗮𝗹𝘆𝘀𝘁 to boost emerging biotech success. Learn more: certara.com/services/bio-ven…

Pregnant women are excluded from drug trials, leaving critical treatment gaps. In a new interview in The Medicine Maker, Karen Rowland Yeo explains how PBPK modeling can fill the evidence gaps that clinical trials alone cannot: themedicinemaker.com/issues/… #WomensHealth

Pregnant women are excluded from drug trials, leaving critical treatment gaps. In a new interview in The Medicine Maker, Karen Rowland Yeo explains how PBPK modeling can fill the evidence gaps that clinical trials alone cannot: themedicinemaker.com/issues/… #WomensHealth

Fewer late-stage surprises start with earlier insight. Certara IQ™ turns QSP into a scalable decision engine—helping teams identify infeasible programs earlier, reduce dose uncertainty, and make faster go/no-go decisions. Book a demo: ow.ly/QgUi50Y0e59 #QSP #MIDD

We're excited to welcome Akiko Watanabe to Certainty Japan 2026! Join her session on PBPK in DDI evaluation. 𝗗𝗮𝘁𝗲 𝗝𝗨𝗡𝗘 𝟮𝟯, 𝟮𝟬𝟮𝟲. Register: ow.ly/4VPs50Z6F7E #CertaintyAPAC2026 #MIDD #M&S #Certara

This #PrideMonth, Certara honors the LGBTQ+ community's impact on clinical research and drug development. Happy Pride 🌈

Join our session to see Phoenix WinNonlin and complementary tools working together in Phoenix Cloud and discover how to simplify your daily workflow. Register today: ow.ly/ylbG50Z4bbU

Scaling QSP starts with the right platform. Certara IQ™ is an AI-enabled, cloud-based solution to standardize models, accelerate development, and run scalable simulations. See it live at our Global Roadshow: ow.ly/jcBw50Yij1A #CertaraIQ #QSP

The EMA launches a pilot for Model-Informed Drug Development, advancing ICH M15 guideline adoption. Watch the webinar: ow.ly/A6If50Z12Mn #EMA #MIDD #ICHM15 #Pharmacometrics #PBPK #QSP #MBMA #DrugDevelopment

Can plasma biomarkers replace PET scans in Alzheimer's trials? New QSP study reveals key insights on treatment response, biomarker impact, and patient benefits. Read more: ow.ly/c2ps50YYplN #Alzheimers #QSP #Biomarkers #ClinicalTrials #MIDD

Join Certara's experts May 21, 11 AM ET for a webinar on minimizing risk in Hepatic Impairment studies. Register: ow.ly/nsb350YYnOY #DrugDevelopment #PBPK #Pharmacometrics #MIDD #ClinicalResearch

A new U.S. Executive Order boosts psychedelic therapy momentum—what does it mean for researchers and compliance? Read more: ow.ly/gRQ050YXPV8 #Psychedelics #DrugDiscovery #FDA #ControlledSubstances #ComplianceChecker

QSP—rebuilt for scale. Certara IQ™ removes QSP bottlenecks with pre-validated models, AI-guided workflows, and secure cloud collaboration—so teams move faster with confidence. Request a demo: ow.ly/QgUi50Y0e59 #CertaraIQ #QSP #MIDD

Watch our new on-demand webinar to hear Certara experts share evolving global expectations, model credibility frameworks, integrated evidence generation, and practical strategies for aligning MIDD approaches with regulatory decision making. ow.ly/KQOC50YYlnt

Our latest blog explores how model-informed drug development (MIDD) enables a continuous, integrated strategy across the ADC lifecycle, from dose optimization to labeling and market access. Read more: ow.ly/KILN50YVzTf #ADC #MIDD #Pharmacometrics #Oncology

Pinnacle 21 Community validates—but Enterprise goes further. Enterprise adds audit trails, cross-study standards governance, automated deliverables, and submission readiness insights. See the full comparison: ow.ly/SEFi50YvYQl #CDISC #DataStandards #Pinnacle21

Pharma is digital, but payer engagement lags with under 7% spend. 👉 Read how to close the gap: certara.com/blog/how-pharmac… #Certara #PayerEngagement #HEOR #ValueCommunication